Journal of Targeted Oncology Research

Frequency : Quarterly (Four issues per year)
Editorial & Review Timeline
3 - 6 Days Initial Quality Review
30 Days Peer Evaluation Summary
45 - 60 Days Complete Editorial Processing Time

Immuno-Oncology

Immuno-Oncology focuses on therapies like immune checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines, which enhance immune responses against tumors. This approach offers durable, personalized treatment, transforming cancer care by improving survival and reducing relapse rates